What do you think CHTP's next move is going to be? Try to get FDA approval or run another Phase III trial?
Run another Phase III. I don't think they'll have a choice in the matter...FDA made their decision in July.
Why cant the FDA just look at the data from the use of the drug in Japan? Explain to me the need for another phase 3 trial
Sentiment: Strong Buy